Literature DB >> 16956789

Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan.

Fuminaka Sugauchi1, Etsuro Orito, Tomoyoshi Ohno, Yasuhito Tanaka, Atsushi Ozasa, Jong-Hon Kang, Joji Toyoda, Tomoyuki Kuramitsu, Kazuyuki Suzuki, Eiji Tanaka, Yoshihiro Akahane, Takafumi Ichida, Namiki Izumi, Kazuaki Inoue, Hiromi Hoshino, Shiro Iino, Hiroshi Yotsuyanagi, Shinichi Kakumu, Eiichi Tomita, Takeshi Okanoue, Shuhei Nishiguchi, Yoshikazu Murawaki, Keisuke Hino, Morikazu Onji, Hiroshi Yatsuhashi, Michio Sata, Yuzo Miyakawa, Ryuzo Ueda, Masashi Mizokami.   

Abstract

Genotypes of hepatitis B virus (HBV) were determined in 485 patients with acute hepatitis B from all over Japan. They were A in 92 (19%), Ba in 26 (5%), Bj in 32 (7%), C in 330 (68%) and D in 5 (1%). Sexual contacts were the main route of transmission in them. Overall, HBV persisted in only 5 of the 464 (1%) followed patients. Genotypes C accounted for more than 68% in northern as well as southern areas, contrasting with genotype A accounting for 34% in and around the Metropolitan areas. During 24 years from 1982 to 2005, genotype A increased from 5% to 33%, while genotype B gradually decreased from 26% to 8%. Fulminant hepatitis was significantly more frequent in infection with genotype Bj (41%) than those with the other genotypes (p<0.01). The core-promoter double mutation (T1762/A1764) and precore stop-codon mutation (A1896) were more frequent in patients with fulminant than acute self-limited hepatitis (57% versus 15% and 58% versus 10%, respectively, p<0.01 for both). In conclusion, genotype A distributes unevenly over Japan, prevails in younger patients through sexual transmission and has increased with years. Furthermore, fulminant outcome was more frequent in patients with genotype Bj than those with the other genotypes.

Entities:  

Year:  2006        PMID: 16956789     DOI: 10.1016/j.hepres.2006.06.001

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  10 in total

1.  Natural history of chronic hepatitis B virus infection in children in Japan: a comparison of mother-to-child transmission with horizontal transmission.

Authors:  Tomoko Takano; Hitoshi Tajiri; Satoyo Hosono; Ayano Inui; Jun Murakami; Kosuke Ushijima; Yoko Miyoshi; Yuri Etani; Daiki Abukawa; Mitsuyoshi Suzuki; Stephen Brooks
Journal:  J Gastroenterol       Date:  2017-02-09       Impact factor: 7.527

2.  Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis.

Authors:  Xueyuan Nian; Zhihui Xu; Yan Liu; Jianhong Chen; Xiaodong Li; Dongping Xu
Journal:  Hepatol Int       Date:  2016-03-16       Impact factor: 6.047

3.  A fatal case of acute hepatitis B developed in a toluene abuser.

Authors:  Hideaki Kato; Jun Monma-Ohtaki; Makoto Nakamura; Yuji Nishi; Makoto Ohyama; Yoshitaka Maeno; Yoshimi Seko-Nakamura; Saeko Nagao; Masataka Nagao
Journal:  Clin J Gastroenterol       Date:  2008-05-16

4.  Hepatitis B virus genotype B and mutations in basal core promoter and pre-core/core genes associated with acute-on-chronic liver failure: a multicenter cross-sectional study in China.

Authors:  Guifeng Yang; Meifang Han; Feng Chen; Ying Xu; Enqiang Chen; Xiaojing Wang; Yu Liu; Jian Sun; Jinlin Hou; Qin Ning; Zhanhui Wang
Journal:  Hepatol Int       Date:  2014-07-31       Impact factor: 6.047

5.  Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A.

Authors:  Kentaro Matsuura; Yasuhito Tanaka; Shuhei Hige; Gotaro Yamada; Yoshikazu Murawaki; Masafumi Komatsu; Tomoyuki Kuramitsu; Sumio Kawata; Eiji Tanaka; Namiki Izumi; Chiaki Okuse; Shinichi Kakumu; Takeshi Okanoue; Keisuke Hino; Yoichi Hiasa; Michio Sata; Tatsuji Maeshiro; Fuminaka Sugauchi; Shunsuke Nojiri; Takashi Joh; Yuzo Miyakawa; Masashi Mizokami
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

6.  Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study.

Authors:  Tetsuya Hosaka; Fumitaka Suzuki; Masahiro Kobayashi; Yuya Seko; Yusuke Kawamura; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Mariko Kobayashi; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2012-10-12       Impact factor: 7.527

7.  Inhibitory effect of silibinin on hepatitis B virus entry.

Authors:  Teruyuki Umetsu; Jun Inoue; Takayuki Kogure; Eiji Kakazu; Masashi Ninomiya; Tomoaki Iwata; Satoshi Takai; Takuya Nakamura; Akitoshi Sano; Tooru Shimosegawa
Journal:  Biochem Biophys Rep       Date:  2018-03-31

Review 8.  Countermeasures against viral hepatitis B and C in Japan: An epidemiological point of view.

Authors:  Junko Tanaka; Tomoyuki Akita; Ko Ko; Yoshihiko Miura; Masahiro Satake
Journal:  Hepatol Res       Date:  2019-08-22       Impact factor: 4.288

9.  Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis.

Authors:  X Ren; Z Xu; Y Liu; X Li; S Bai; N Ding; Y Zhong; L Wang; P Mao; F Zoulim; D Xu
Journal:  J Viral Hepat       Date:  2010-12       Impact factor: 3.728

10.  Association of Hepatitis B Virus Mutations of A1846T and C1913A/G With Acute-on-Chronic Liver Failure Development From Different Underlying Chronic Liver Diseases.

Authors:  Aimin Zhang; Zhihong Wan; Shaoli You; Hongling Liu; Bing Zhu; Jing Chen; Yihui Rong; Hong Zang; Chen Li; Huifen Wang; Shaojie Xin
Journal:  Hepat Mon       Date:  2013-09-01       Impact factor: 0.660

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.